Are GLP-1 Drugs Safe? Patients File Lawsuits in Marion Co. Over Alleged Side Effect Cover-Up
Are you taking a GLP-1 drug to lose weight? You're not alone. Millions of Americans are turning to these popular medications, sold under names like Ozempic, Wegovy, Zepbound, and Mounjaro, to treat diabetes, obesity, and other health conditions. But as WRTV Investigates uncovers in a week-long series, these drugs come with potential side effects, and some patients are now taking legal action.
Sue Seyfert, an Indiana native, considers herself lucky. She's never experienced any side effects from taking Ozempic for diabetes. However, many others are not so fortunate. WRTV Investigates found dozens of patients claiming serious side effects from GLP-1 drugs, including gastroparesis, a condition where the stomach struggles to empty itself.
The controversy? Drug companies are accused of downplaying these side effects. Lawsuits filed in Marion County against Eli Lilly and Novo Nordisk, the makers of Trulicity, Ozempic, and Victoza, claim the companies failed to warn consumers about potential risks like muscle loss and gastroparesis. Instead, they allegedly invested in developing combination drugs to combat these issues.
One lawsuit, filed by Terry Smith, alleges that after using Ozempic, Trulicity, and Victoza, he suffered from gastroparesis, debilitating vomiting, and abdominal pain, requiring emergency medical treatment. Smith is seeking damages from Eli Lilly and Novo Nordisk.
But what about the benefits? GLP-1 drugs have shown promise in improving health outcomes, particularly for those with obesity/overweight. They've demonstrated reductions in CV death, stroke, and myocardial infarction. However, the controversy surrounding their side effects and the financial ties between pharmaceutical companies and doctors raises important questions.
On Wednesday, WRTV News at 6 pm will delve into the financial links between pharmaceutical companies and Indiana doctors. Stay tuned for more insights as WRTV Investigates continues to uncover the truth behind these controversial drugs.
